Catabasis Pharmaceuticals (CATB) Priced

Developing combined therapies for Duchenne muscular dystrophy and high cholesterol.

Health Care - Biotechnology

IPO Performance
Latest Trade $1.21 0.00 (0.0%)
First Day Return 8.3%
Return from IPO -89.9%
 
Catabasis Pharmaceuticals IPO News more
  • .
IPO Data
IPO File Date 05/13/2015
Offer Price $12.00
Price Range $13.00 - $15.00
Offer Shares (mm) 5.0
Deal Size ($mm) 60
 
IPO Data
IPO Date 06/24/2015
Offer Price $12.00
Price Range $13.00 - $15.00
Offer Shares (mm) 5.0
Deal Size ($mm) $60
 
Underwriters
more
Business Overview
Developing combined therapies for Duchenne muscular dystrophy and high cholesterol.
Developing combined therapies for Duchenne muscular dystrophy and high cholesterol.
more
Company Data
Headquarters Cambridge, MA
Founded 2008
Employees 34
Website www.catabasis.com
 

Performance vs. IPO Index (IPOUSA)